Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$ASPI ASP Isotopes Inc. (Nasdaq: ASPI) aims to play a crucial role in advancing quantum computing, a field that holds tremendous potential for industries ranging from medicine and artificial intelligence to cybersecurity, global logistics, and global financial systems.
$AVRW News: The Sera Labs, Inc. Announces Partnership With LA-Based Facial Plastic Surgeon Dr. Michael Persky to Support Latest DNA Complex Product Launch
Persky To Also Join Brand's Medical Advisory Board for Future Innovation
SHERMAN OAKS, CA / ACCESSWIRE / September 12, 2023 /The Sera Labs, Inc. ("Sera Labs"), a subsidiary of Avenir Wellness Solutions, Inc. ("Avenir" or the "Company") (OTC PINK: AVRW), a proprietary broad platform technology and wellness company, announced today that renowned plastic surgeon Dr. Michael A. Persky, M.D., F.A.C.S., has joined the Company as a welcome addition to the Medical Advisory Board who will help support marketing for the brand's latest launches and advise on new product innovation.
Board-certified and fellowship-trained, Dr. Persky has specialized in facial plastic surgery for almost 40 years. Throughout his career, Dr. Persky has prioritized non-invasive and non-surgical procedures wherever possible and is always looking for products to recommend to patients before they commit to an invasive surgical procedure.
This partnership came about through a long-standing relationship with Nancy Duitch, Avenir CEO and Founder of Sera Labs. In this role, Dr. Persky will support brand marketing, social, and advertising campaigns for the brand's latest innovation, patent-pending DNA (Deep Nano Actives) Complex, an instant anti-aging skin tightening serum that penetrates deep into the skin. As an advisory board member, Dr. Persky will also advise on formulating the brand's future plant-based and scientifically grounded products.
"This is the first time that I'm endorsing an over-the-counter skincare product, and what's convinced me to do so is the science behind it, the peptide technology, and my personal experience with it," said Dr. Michael Persky. "I'm all about the truth and can't recommend something unless it's safe, effective, and helps people."
Michael A. Persky, M.D., F.A.C.S.
Facial Plastic Surgeon
The Sera Labs, Inc. Medical Advisory Board
"We are thrilled to bring on Dr. Michael Persky to help us bring more awareness to our most recent innovation, DNA Complex, and advise on the future of our brand portfolio," said CEO Nancy Duitch. "The consumer response and demand thus far for DNA Complex has been overwhelmingly positive. And now, we are excited to continue to grow awareness for this revolutionary product that provides notable results within minutes. Dr. Persky's expertise helps us to offer consumers a non-invasive alternative, continuing the democratization of skincare and our brand's mission of meeting the consumer where they are at."
DNA Complex retails at $99.99 and is currently available for purchase at: https://seralabshealth.com/pages/introducing-dna-complex
AboutAvenir Wellness Solutions, Inc.
Avenir Wellness (OTC PINK: AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that is part of its incubator strategy in order to monetize its intellectual property by expanding its product lines utilizing the technology. And, as a vertically integrated platform company, Avenir also looks to partner or license its IP technology with wellness companies worldwide. For more information visit: http://www.avenirwellness.com.
About The Sera Labs, Inc.
The Sera Labs, Inc. ("Sera Labs"), a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories beauty, health & wellness, Sera Labs products are sold direct-to-consumer (DTC) via online website orders, including opt-in subscriptions, and also sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers and on Amzon.com. For more information visit: www.seralabshealth.com and follow Sera Labs on Facebook and Instagram at @seratopical, as well as on X (Twitter) at @sera_ labs.
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.
Contacts:
Media
Autumn Communications
E: seratopical@autumncommunications.com
T: (212) 206-9780
Investor Relations
Hanover International Inc.
E: investor@avenirwellness.com
T: (760) 564-7400
SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)
View source version on accesswire.com:
https://www.accesswire.com/783058/the-sera-labs-inc-announces-partnership-with-la-based-facial-plastic-surgeon-dr-michael-persky-to-support-latest-dna-complex-product-launch
$EVKRF Grid Battery Metals Inc. (OTCQB: EVKRF) (TSXV: CELL) is unveiling a world of exciting possibilities within the thriving battery metals sector, positioning itself as a compelling area of exploration for researchers. (15) With the electric vehicle battery market projected to reach a staggering $276.40 billion by 2030, the demand for battery metals is skyrocketing
$EVKRF Rising Demand:
With an evident surging demand for EV Battery Metals, in addition to Biden’s Inflation Reduction Act, which pushes for more North American sources of battery metals, Grid Battery Metals Inc. (OTCQB: EVKRF) (TSXV: CELL) aligns its operations with these prevailing industry dynamics
$SYTA Growth continued to accelerate for Siyata Mobile (NASDAQ:SYTA) in the second quarter with a 180% year-over-year increase in revenue
$EVKRF The European Union's "Critical Raw Materials Act" of 2023 seeks to ensure a sustainable supply chain. The U.S., too, is leaning towards domestic sourcing. This shift has shone the spotlight on companies with domestic mining footprints for these crucial minerals. Among these, Grid Battery Metals Inc. (OTCQB:EVKRF)(TSX.V:CELL), alongside others like Surge Battery Metals and Century Lithium, emerges as a potential promising name.
$EVKRF AUSTIN, TX / ACCESSWIRE / July 26, 2023 / SmallCapVoice.com Inc, is thrilled to announce the availability of an exclusive interview featuring Tim Fernback, the CEO of Grid Battery Metals (TSXV:CELL) (OTCQB:EVKRF) (FRA:NMK2), as he delves into the exciting prospects of nickel and lithium in the rapidly expanding electric vehicle (EV) and battery sectors.
Grid Battery Metals, a pioneering company, is strategically positioned in the battery metals market, with a strong focus on nickel and lithium. As the demand for EVs and battery technologies soars, both nickel and lithium are projected to experience significant growth over the next decade.
$TOON Management team
https://ir.kartoonstudios.com/management-team
$TOON Kartoon Studios has announced its foray into the comic book universe, partnering with LEGIBLE INC. Digital collectibles saw a whopping 8,000 units being snapped up in collaboration with VeVe. The recent launch of a Stan Lee documentary on Disney+, post a successful stint at The Tribeca Festival, further underscores Kartoon Studios’ dedication to magnifying the legend’s legacy.
$TOON Latest News and Headlines https://www.barchart.com/stocks/quotes/TOON/news
$AVRW: Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
New Branding Reflects Company's Commitment to the Future of Wellness
SHERMAN OAKS, CA / ACCESSWIRE / August 8, 2023 / Avenir Wellness Solutions, Inc. (OTC Pink:CURR) ("Avenir" or the "Company"), a proprietary broad platform and wellness technology company, today announced that it has received regulatory approval to officially change its ticker symbol from "CURR" to "AVRW" effective at the stock market opening on August 9, 2023. The ticker symbol change follows the corporate name change to "Avenir Wellness Solutions, Inc." in October 2022. The name change reflects the renewed focus of the Company with its incubator strategy and continuing efforts to create and commercialize wellness technologies with quality products and brands in the wellness and beauty space. In connection with the name change, the Company previously launched a new corporate website at: www.avenirwellness.com.
"This re-branding opened a new chapter for the Company beginning last year with strategic and deliberate changes. As we continue to focus on our short and long-term growth strategy by steadily increasing revenue with high margin products, we are also broadening our wellness platform technology using an incubator strategy to monetize its intellectual property. We fully intend to continue creating new innovative technologies supported with intellectual property to not only grow the business but grow the Company's shareholder value as well," stated Nancy Duitch, Avenir CEO.
The Company's common stock will continue to be traded on OTC Pink Market and the CUSIP number will not be changing. The Company has reapplied to move its common stock back to the OTCQB now that all delinquent filings have been filed with the U.S. Securities and Exchange Commission.
This rebranding is part of the Company's shareholder value initiatives and ongoing commitment to delivering innovative and highly desired wellness technologies to the marketplace. The Company's long-term growth strategy is to increase revenue with high margins, use its incubator strategy to grow the patent and product portfolio as well as monetize the IP patent technology through strategic partnerships. These initiatives, along with the Company's relationships with Nicole Kidman and other major social media influencers, is expected to help propel its health and beauty products to become a household name, consistent with its strategy to become a genuine house of recognizable and respected quality brands.
"Providing cutting edge products, proprietary delivery systems, and impactful marketing strategies to an enormous health and wellness industry that is desperate for new innovations and solutions is the key for us to becoming a House of Quality Brands. Rebranding the Company and delivering on our value proposition is very exciting, and it will ultimately increase shareholder value," continued CEO Nancy Duitch.
For more information, please visit: www.avenirwellness.com and www.seralabshealth.com
About Avenir Wellness Solutions, Inc.
Avenir Wellness Solutions, Inc. (OTC Pink:AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that will be part of its incubator strategy in order to monetize its IP. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: www.avenirwellness.com.
About The Sera Labs, Inc.
Sera Labs, a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories beauty, health & wellness, Sera Labs sells products direct-to-consumer (DTC) via online website orders, including opt-in subscriptions, under private label to multi-level marketers and sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers. For more information visit: www.seralabshealth.com and follow Sera Labs on Facebook and Instagram at @seratopical, as well as on Twitter at @sera_labs.
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.
Contacts:
Media
Autumn Communications
E: seratopical@autumncommunications.com
T: (212) 206-9780
Investor Relations
Hanover International Inc.
T: (760) 564-7400
E: investor@avenirwellness.com
SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)
View source version on accesswire.com:
https://www.accesswire.com/773094/Avenir-Wellness-Solutions-Announces-New-Ticker-Symbol-As-Final-Part-of-Exciting-New-Brand-Identity
$BCAN BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) could have a higher potential for growth given their status in the market as a micro-cap.
$BCAN Higher Potential for Growth:
In general, micro-cap companies have market capitalizations of between $50 million and $300 million. (17) Because micro-cap stocks are significantly smaller than mid-cap or large-cap companies, they have a higher potential to change valuation quickly. (17) As of 7/19/23, BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) has a market cap of approximately $51.49M according to MarketWatch.com.
$CURR Avenir Wellness $CURR DNA Complex retails for $79.99 USD and is currently available at: https://seralabshealth.com/discount/INVESTOR20
20% Discount with Code: INVESTOR20
Learn more here: CURR CEO Nancy Duitch, discussing how she has spent her entire career working on solution-based health, wellness and beauty products to help people look and feel their best.
https://podcasts.apple.com/us/podcast/lifetime-of-health-and-wellness-nancy-duitch-ceo/id1211773564?i=1000608721227
$IVDN: Increasing Orders and Insider Share Purchase; Patented Evacuated Cell Insulation; Innovative Designs: Stock Symbol: IVDN
Click here:
https://www.einpresswire.com/article/637864225/increasing-orders-and-insider-share-purchase-patented-evacuated-cell-insulation-innovative-designs-stock-symbol-ivdn
From the article:
- $IVDN has a Very Small Stock Structure of Only 36 Million OS / 16 Million Float
- Sole Maker of Patented Insultex® Insulation Delivering Energy Saving Performance Far Superior to All Competition.
- Greater Energy Savings from Insultex® Insulation Delivers Essential Benefits of Economic Gains for the User and Carbon Reduction for the Environment.
- Significant New Orders for Insultex House Wrap® from Repeat Customers.
- Insider Buying from Board Member with Lockheed Martin & NASA Background.
- New US Patent Issued for Insultex® Manufacturing Process.
- International Distributor Agreement Signed with a Minimum Order Valued at $2 Million Per Year.
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
$PLPL ByoPlanet's intellectual property, innovative products/services, customer-centric approach, and strategic market positioning have contributed to an assessment of ByoPlanet's current and growing market acceptance and competitive advantage.
$KRTL Recent news can be found here https://www.krtlholding.com/news
$KRTL ~ KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has a focus in the biotechnology space.
$KRTL ~ KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has a focus in the biotechnology space.
$HMBL HUMBL Social is the newest alternative for social media that allows verified users to connect to other verified accounts. All users must go through a 3rd party verification process in order to be approved to interact on the platform. Find, follow, and connect with other verified accounts.
$HMBL Humbl search engine has bothe web 2 and web 3 blockchain capabiities.
$HMBL Wallet is 4.9 stars and has more features than Meta Mask.
$HMBL San Diego, California, May 15, 2023 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTCQB: HMBL) announced today that it has entered into an Equity Financing Agreement with Pacific Lion LLC (Pacific Lion) pursuant to which Pacific Lion agreed to purchase up to $20,000,000 of HUMBL common stock. Pacific Lion also agreed to fund HUMBL up to $800,000 under a Convertible Promissory Note to bridge HUMBL through to the effectiveness of the registration of the shares to be sold under the Equity Financing Agreement. In addition to the transactions with Pacific Lion, HUMBL also raised $220,000 through the sale of common stock and warrants to a group of private investors.
https://seekingalpha.com/pr/19333513-humbl-receives-funding-commitment-of-up-to-21-million-initial-step-in-comprehensive-plan-to
$HMBL Wallet is 4.9 stars and has more features than Meta Mask.
$MGRX News being liked here
Mangoceuticals Inc
1.1896
+0.0196 (+1.68%)
$EPAZ featured in another CapitalGainsReport article! >>
CapitalGainsReport: The Future of Reality: Four AR Stocks You Don't Want to Miss (EPAZ, NEXCF, SNAP, HIMX)
Augmented reality (AR) is a truly remarkable and cutting-edge technology that has the power to revolutionize the way we perceive and interact with the world around us. Unlike virtual reality, which creates a whole new world for users to explore, AR enhances the existing environment by seamlessly integrating virtual elements into it. This means that users can experience a heightened, more interactive version of reality like never before.
AR is already transforming businesses and changing the way consumers engage with them, but its potential applications are limitless. In this article, we'll delve into four exciting companies at the forefront of the AR revolution and explore how they're harnessing this incredible technology to create innovative solutions that are transforming various industries. If you're looking for the next big thing in technology, then AR could be the space to watch!
The first stock on the augmented reality watchlist is a newcomer to the space. Epazz, Inc. (OTC:EPAZ) is a mission-critical provider of metaverse solutions, drone technology, blockchain cryptocurrency mobile apps, and cloud-based business software solutions.
Last week, Epazz announced the development of a groundbreaking new product: low-cost augmented reality smart glasses called Stacklens. These durable and comfortable smart glasses are set to revolutionize the service industry, particularly field service companies, by providing access to affordable smart augmented reality glasses. Stacklens will cost less than $400 per pair, which is significantly cheaper than the $2,000 price tag of other similar products on the market.
The company decided to develop Stacklens because they noticed that third-party glasses were too expensive and caused sticker shock for potential customers in Europe who wanted to use the technology. Now, with Stacklens, organizations can use innovative technology at a low cost, enabling the company to win more deals. Stacklens is ideal for technicians in the field who need to fix complex machines such as HVAC, industrial machines, water, and waste pipes. The technology is also attracting interest in aircraft maintenance.
Epazz has submitted a proposal to the armed forces to use the technology in the field and has received feedback from the United States military about using First Person View smart glasses with ZenaDrone 1000. The company plans to continue improving the technology for use with ZenaDrone 1000, a first-person view smart glasses product with augmented reality technology.
Combining their drone technology with the low-cost augmented reality smart glasses, Stacklens, can potentially result in increased revenue for Epazz, particularly from government contracts. The United States military has already expressed interest in using their First Person View smart glasses with ZenaDrone 1000, and Epazz plans to further develop this technology. Their focus on meeting the needs of their customers by developing affordable and durable products like Stacklens highlights their commitment to innovation and customer satisfaction. As a newcomer to the augmented reality space, Epazz's potential for growth is exciting to watch.
$CBGL Traders Cheat Sheet https://cannabisglobalinc.com/new-brand-botan/
$CBGL Quote https://www.otcmarkets.com/stock/CBGL/quote
$CURR Seratopical Products featured here today: Nicole Kidman’s Flawless Met Gala Skin Called on This Facelift in a Bottle That’s Selling Fast
By Eva Thomas Published on May 2, 2023
LINK:
https://www.instyle.com/nicole-kidman-met-gala-2023-seratopical-revolution-7487698?utm_source=twitter&utm_medium=social&utm_campaign=shareurlbuttons
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
$EMED Electricity enables information to circulate in the body, electrotherapy manipulates a specific part of the information by pulsating electrical waves interfering with the transmission of pain signals.
Our nervous system is composed of our brain and our spinal cord, which combine to form the central nervous system; and our sensory and motor nerves, which form the peripheral nervous system. Nerves send information about what is happening in our environment to the brain via the spinal cord. The brain then sends information back to our nerves, helping us to perform actions in response. By treating specific body areas and varying frequency, wavelength and intensity applied, electrotherapy devices can manipulate impulses and target actions to alleviate pain or they can disrupt pain signals.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Our mission
Over 80 million Americans live with moderate to severe pain resulting from an accident or a disease, nearly 40% of them report being unable to find adequate pain relief and 77% report feeling depressed due to their chronic pain.
Our goal is to unlock the body’s natural ability to achieve wellness through high performance electrotherapy technologies, using energy, frequency and vibrations to improve quality of life.
Activists of a drug free approach, we take prescription drug misuse very seriously.
Alarming statistics have highlighted the importance of an alternative method for pain management.
https://electromedtech.com/our-mission/
$EMED Electrotherapy can be used to treat a wide range of of acute and chronic pain.
It also supports healing and recovering and can be used for post-surgical discomfort and to boost your body’s natural recovery properties.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
$EMED
The WellnessPro Plus®
triggers our body’s natural processes. Electrical impulses travel from nerves around the injured area to our brain, delivering the unpleasant sensation of pain. WellnessPro Plus® operates by disrupting these pain signals received by our synapses, mimicking our natural electric signals to relieve patients from pain.
Electromedical Technologies brought together some of the leading biomedical researchers from around the world to develop next generation TENS machines. Through product innovation and a forward-thinking approach, we succeeded to develop specific algorithms in electrotherapy that work to alleviate pain.
$EMED During the three months ended Dec 31, preliminary revenue increased 79% on a quarterly year-over-year basis and 51% on a sequential quarterly basis.
$EMED
The WellnessPro Plus®
triggers our body’s natural processes. Electrical impulses travel from nerves around the injured area to our brain, delivering the unpleasant sensation of pain. WellnessPro Plus® operates by disrupting these pain signals received by our synapses, mimicking our natural electric signals to relieve patients from pain.
Electromedical Technologies brought together some of the leading biomedical researchers from around the world to develop next generation TENS machines. Through product innovation and a forward-thinking approach, we succeeded to develop specific algorithms in electrotherapy that work to alleviate pain.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Our mission
Over 80 million Americans live with moderate to severe pain resulting from an accident or a disease, nearly 40% of them report being unable to find adequate pain relief and 77% report feeling depressed due to their chronic pain.
Our goal is to unlock the body’s natural ability to achieve wellness through high performance electrotherapy technologies, using energy, frequency and vibrations to improve quality of life.
Activists of a drug free approach, we take prescription drug misuse very seriously.
Alarming statistics have highlighted the importance of an alternative method for pain management.
https://electromedtech.com/our-mission/
$EMED Quote https://www.otcmarkets.com/stock/EMED/quote